NCT07157254 A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS) Status RECRUITING Phase PHASE2
NCT06617429 Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06415344 Long-term Extension of GTX-102 in Angelman Syndrome Status ENROLLING_BY_INVITATION Phase PHASE3
NCT04259281 A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome Status COMPLETED Phase PHASE1/PHASE2